Researchers at the University of Sydney and Centenary Institute are repurposing an existing tuberculosis vaccine to see if it can be used in a new way against COVID-19 to develop a novel vaccine.
Jul 3, 2020
0
19
An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington School of Medicine in Seattle report in a paper published by the ...
Nov 3, 2022
0
2102
A single shot of one of the currently authorized COVID-19 vaccines may be sufficient to provide immunity to individuals who have previously been infected by the virus, thus eliminating the need for a second dose and helping ...
Mar 10, 2021
0
297
The preclinical data for a vaccine developed at MedUni Vienna to protect against SARS-CoV-2 indicates that it is effective against all SARS-CoV-2 variants known to date, including omicron—even in those who have not yet ...
Apr 5, 2022
0
297
Perhaps the most important question now about COVID-19 is the degree to which a prior infection protects from a second infection by the new coronavirus. This affects vaccine development and herd immunity and is something ...
Jun 12, 2020
0
8
With nearly 5 million confirmed cases globally and more than 300,000 deaths from COVID-19, much remains unknown about SARS-CoV-2, the virus that causes the disease. Two critical questions are whether vaccines will prevent ...
May 20, 2020
0
920
Uli von Andrian is the Mallinckrodt Professor of Immunopathology at Harvard Medical School and Program Leader of Basic Immunology at the Ragon Institute of MGH, MIT, and Harvard.
Apr 10, 2020
0
60
Our internal 24-hour circadian clock regulates many aspects of physiology, including the response to infectious disease and vaccination. A new study published in the Journal of Biological Rhythms demonstrates that antibody ...
Dec 7, 2021
0
47
If smoking a cigarette no longer delivers pleasure, will smokers quit? It's the idea behind a nicotine vaccine being created by MIT and Harvard researchers, in which an injection of synthetic nanoparticles prompts the immune ...
In a Perspective piece published in the journal Science, a small international team of researchers is suggesting that the oral polio vaccine be tested to see if it might protect people from infection by the SARS-CoV-2 virus. ...
